Ellen Wright Clayton, M.D., J.D., is the Rosalind E. Franklin Professor of Genetics and Health Policy; Co-Director, Center for Biomedical Ethics and Society; Senior Fellow, Institute for Public Policy Studies; Professor of Law; and Professor of Pediatrics at Vanderbilt University. Dr. Clayton has been studying and teaching the ethical, legal, and social implications of developments in genetics for more than a quarter of a century and has published two books and more than 75 peer-reviewed articles and book chapters. She has been an active participant in policy debates advising the National Human Genome Research Institute as well as numerous other federal and international bodies on an array of topics, ranging from issues in children’s health, including newborn screening, to the ethical conduct of research involving human subjects. In these roles, she has helped develop policy for numerous national and international organizations. Dr. Clayton is a member of the Health Sciences Policy Board of the Institute of Medicine, and has served on a number of other IOM committees.
Manning Feinleib, M.D., M.P.H., Dr.P.H. (IOM member), is Professor in the Department of Epidemiology at the Bloomberg School of Public Health of The Johns Hopkins University. He was Director of the National Center for Health Statistics from 1983 to 1995. His research interests include epidemiology of cardiovascular diseases with emphasis on demographic and secular trends, international comparisons, and effects of socioeconomic factors, nutrition, and prevention; vital statistics, population surveys, and linkage of data bases with emphasis on confidentiality issues, improving data quality, and facilitating research uses of large data bases. Dr. Feinleib is on the editorial board of the American Journal of Epidemiology. He is the recipient of the 2004 American College of Epidemiology Abraham Lilienfeld award for lifetime contributions to the field. Among his contributions to National Academies studies is his service on a recent IOM Panel on Gulf War and Health.
Mark S. Goldberg, Ph.D., is Associate Professor in the Department of Medicine, McGill University, Montreal, and Associate Member in their joint Departments of Epidemiology and Biostatistics and Occupational Health, and in the Department of Oncology. He is also Medical Scientist in the Royal Victoria Hospital, McGill University Health Centre. Dr. Goldberg is an occupational and environmental epidemiologist and holds an Investigator Award from the Canadian Institutes of Health Research. His current research interests include the investigation of occupational and environmental risk factors for cancer and the health effects associated with exposures to ambient air pollution. In addition to being a member of grant review panels, Dr. Goldberg was also a member of the McGill University Institutional Review Board, and is a member of Health Canada’s Science Advisory Board. He has also served on a number of other National Academies committees.